» Articles » PMID: 11217927

Familial Primary Pulmonary Hypertension and Associated Ocular Findings

Overview
Journal Retina
Date 2001 Feb 24
PMID 11217927
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial primary pulmonary hypertension (PPH) is a rare, fatal, autosomal dominant disease that results in right heart failure from idiopathic obliteration of the pulmonary arteries. Patients develop stagnation of venous blood flow and elevated venous pressure.

Methods: The authors retrospectively reviewed the clinical records of three patients diagnosed with PPH that was confirmed on the basis of physical examination, chest X-ray, electrocardiogram, and echocardiogram. Cardiac catheterization excluded cardiac shunt and other secondary causes of pulmonary hypertension.

Results: Two patients presented with a clinical picture resembling venous stasis retinopathy, and one with bilateral choroidal detachments. Two patients had delayed choroidal filling on fluorescein angiography, which was confirmed in one patient with indocyanine green videoangiography.

Conclusions: Elevated venous pressure found in PPH is responsible for the delayed choroidal perfusion and the reduced venous blood outflow. This explains the clinical findings of venous stasis retinopathy and choroidal detachments seen in these patients.

Citing Articles

Retinal vascular changes and right ventricular structure and function: the MESA-Right Ventricle and MESA-Eye studies.

Chyou A, Klein B, Klein R, Barr R, Cotch M, Praestgaard A Pulm Circ. 2019; 9(1):2045894018819781.

PMID: 30622700 PMC: 6304712. DOI: 10.1177/2045894018819781.


Bilaterally dilated episcleral vessels in patients with heritable pulmonary arterial hypertension.

Watanabe M, Makino S, Obata H J Gen Fam Med. 2017; 18(6):464-465.

PMID: 29264093 PMC: 5729320. DOI: 10.1002/jgf2.89.


A case study of ciliary detachment with primary pulmonary hypertension.

Feng Z, Dong L, Cao J, Bai J, Yang M, Zheng Y Int Ophthalmol. 2017; 38(1):375-379.

PMID: 28108900 DOI: 10.1007/s10792-017-0443-4.


Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Wirostko B, Tressler C, Hwang L, Burgess G, Laties A BMJ. 2012; 344:e554.

PMID: 22354598 PMC: 3283528. DOI: 10.1136/bmj.e554.


[Retinal diseases with primary pulmonary hypertension].

Beck R, Eckard A, Ewert R, Guthoff R Ophthalmologe. 2003; 100(9):732-5.

PMID: 14504899 DOI: 10.1007/s00347-003-0841-z.